Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12103902 Bicyclic compounds

Patent 12103902 was granted and assigned to Vivace Therapeutics on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Vivace Therapeutics

0

Current Assignee

Vivace Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Tracy Tzu-Ling Tang Lin0

Andrei W. Konradi0

Date of Patent

October 1, 2024

0

Patent Application Number

177526490

Date Filed

May 24, 2022

0

Patent Citations

US Patent 9012443 Bicyclic aryl and heteroaryl sodium channel inhibitors

0

US Patent 9452986 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use

0

US Patent 11420935 Bicyclic compounds

0

US Patent 9776995 Bicyclic sulfonamide compounds as sodium channel inhibitors

0

US Patent 7718703 Norvaline derivative and method for preparation thereof

0

US Patent 7960409 Pharmaceutical phenylquinoline and chromen-2-one triazole compounds

0

US Patent 8362000 Azetidinyl diamides as monoacylglycerol lipase inhibitors

0

US Patent 8426401 Azetidinyl diamides as monoacylglycerol lipase inhibitors

0

...

Patent Primary Examiner

0

Patent abstract

Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating diseases, such as cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12103902 Bicyclic compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool